Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.130
+0.100 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.000
-0.130 (-4.15%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Xenetic Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -2.68 | -3.96 | -4.13 | -6.55 | -5.65 | |
| Depreciation & Amortization | - | - | - | 0.03 | 0.04 | |
| Asset Writedown & Restructuring Costs | - | - | - | 1.79 | - | |
| Stock-Based Compensation | 0.06 | 0.17 | 0.28 | 0.51 | 0.41 | |
| Change in Accounts Payable | 0.07 | 0.08 | -0.26 | -0.35 | 0.46 | |
| Change in Other Net Operating Assets | 0.26 | 0.89 | 0 | -0.08 | 0 | |
| Operating Cash Flow | -2.29 | -2.82 | -4.11 | -4.65 | -4.74 | |
| Sale (Purchase) of Intangibles | - | - | - | -0.5 | - | |
| Investing Cash Flow | - | - | - | -0.5 | - | |
| Issuance of Common Stock | 4 | - | - | - | 11.45 | |
| Financing Cash Flow | 4 | - | - | - | 11.45 | |
| Net Cash Flow | 1.72 | -2.82 | -4.11 | -5.15 | 6.72 | |
| Free Cash Flow | -2.29 | -2.82 | -4.11 | -4.65 | -4.74 | |
| Free Cash Flow Margin | -76.83% | -112.69% | -161.98% | -272.23% | -408.21% | |
| Free Cash Flow Per Share | -1.34 | -1.83 | -2.69 | -3.27 | -4.61 | |
| Levered Free Cash Flow | -1.38 | -2.19 | -2.85 | -4.56 | -2.29 | |
| Unlevered Free Cash Flow | -1.38 | -2.19 | -2.85 | -4.56 | -2.29 | |
| Change in Working Capital | 0.33 | 0.97 | -0.26 | -0.43 | 0.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.